Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients
- 1 December 2006
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 214 (1), 8-14
- https://doi.org/10.1159/000096906
Abstract
Background: Indoleamine (2,3)-dioxygenase (IDO) catalyses the initial, rate-limiting step in the degradation of the essential amino acid tryptophan. Via tryptophan deprivation, IDO activity suppresses T cell proliferation and differentiation and is thought to be a fundamental immune escape mechanism for tumor cells. Objective and Methods: To investigate the potential role of tryptophan degradation as a prognostic marker, serum tryptophan and kynurenine concentrations and the kynurenine-to-tryptophan ratio (kyn/trp) in 87 patients with malignant melanoma were compared to the course of the disease and to concentrations of the immune activation marker neopterin. Results: Compared to 49 healthy volunteers, the melanoma patients presented with lower tryptophan levels due to accelerated degradation. This was especially true for the subgroups of patients with distant metastases (p = 0.01), though not in patients with lymph node metastases or in patients who had not yet progressed. There existed a positive correlation between kyn/trp and neopterin concentrations (rs = 0.587, p Conclusion: Decreased serum tryptophan concentrations and elevated serum neopterin levels can be used as predictive markers for the future course in melanoma patients. Moreover, our data support previous speculations that a higher degree of IDO expression could play a crucial role for tumor progression.Keywords
This publication has 28 references indexed in Scilit:
- Identifying and Overcoming Immune Resistance Mechanisms in the Melanoma Tumor MicroenvironmentClinical Cancer Research, 2006
- Tryptophan degradation in patients with gynecological cancer correlates with immune activationCancer Letters, 2005
- Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel diseaseClinical Immunology, 2004
- Interferon-γ: an overview of signals, mechanisms and functionsJournal of Leukocyte Biology, 2003
- CTLA-4–Ig regulates tryptophan catabolism in vivoNature Immunology, 2002
- The Hallmarks of CancerCell, 2000
- Correlation between neopterin, interferon‐gamma and haemoglobin in patients with haematological disordersEuropean Journal of Haematology, 1990
- Human macrophages degrade tryptophan upon induction by interferon-gammaLife Sciences, 1987
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958